1 / 4

SWISS TUMOR BOARD Pancreatic Cancer March 26, 2009 Novotel Bern

SWISS TUMOR BOARD Pancreatic Cancer March 26, 2009 Novotel Bern. Prof. Dr. Mahmut Ozsahin. Lausanne University Medical Center (CHUV), Lausanne. Case #3 P. Abitabile, C.A. Maurer. 69-yr-old man June 07: Whipple, R1 August 07 – April 08: gemcitabine chemotherapy with some side effects

ronnie
Télécharger la présentation

SWISS TUMOR BOARD Pancreatic Cancer March 26, 2009 Novotel Bern

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SWISS TUMOR BOARDPancreatic CancerMarch 26, 2009Novotel Bern Prof. Dr. Mahmut Ozsahin Lausanne University Medical Center (CHUV), Lausanne

  2. Case #3P. Abitabile, C.A. Maurer • 69-yr-old man • June 07: Whipple, R1 • August 07 – April 08: gemcitabine chemotherapy with some side effects • December 08: hepatic segment VI lesion, no local recurrence • Good performance status (peripheral neuropathy, chronic renal insufficiency) • Conlusion: Patient may receive preoperative chemotherapy but peripheral neuropathy and renal problem. • Thus, if possible, surgery. If not, radiofrequency ablation • Extracranial stereotactic radiosurgery/radiotherapy may also be an option

  3. Extracranial stereotactic radiosurgery Cyberknife, Novalis, etc

  4. Tomotherapy

More Related